Clinical Trials Logo

Clinical Trial Summary

Newly diagnosed T2DM participants without hypoglycemic drugs intake were retrospective analyzed. Plasma total bile acids in fasting state (FTBAs) and other parameters were compared before and after exenatide treatment and correlation analysis between changes of FTBAs and glycemic parameters.


Clinical Trial Description

Newly diagnosed T2DM participants without hypoglycemic drugs intake were retrospective analyzed. Plasma total bile acids in fasting state (FTBAs) and other parameters were tested at baseline. Then exenatide were applied to the T2DM participants for 12 weeks. FTBAs and glycemic parameters were measured again after exenatide treatment, and correlation analysis between changes of FTBAs and glycemic parameters were conducted to investigate the role of BAs in the glycemic control effect of exenatide. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04303819
Study type Observational
Source Beijing Chao Yang Hospital
Contact
Status Completed
Phase
Start date January 5, 2020
Completion date January 31, 2020

See also
  Status Clinical Trial Phase
Recruiting NCT05606471 - Glucagon-like Peptide-1 Agonism With Very Low Calorie Diets Phase 4
Completed NCT05072990 - Type 2 Diabetes Mellitus With Obesity and Dyslipidemia Treated by Chinese Herbal Medicine
Withdrawn NCT02977039 - Effect of a Plant Rich Diet on in People With Type 2 Diabetes and Obesity N/A
Recruiting NCT06223490 - Effect of Cryolipolysis on Insulin Resistance N/A
Completed NCT04363710 - Prospective Interventional Study on Reversibility of Type 2 Diabetes Mellitus With Hypocaloric Diet N/A
Recruiting NCT05277558 - Brain Health in Youth With Normal Weight, Overweight and Obesity at Risk for Type 2 Diabetes (T2D)
Recruiting NCT04621929 - Obesity and Uric Acid Stones Study Phase 3
Completed NCT04332354 - Glycemic Profile by CGMS in Diabetic Patients After Bariatric Surgery
Completed NCT05890950 - A Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of K-757 and K-833 in Overweight/Obese Patients With Type 2 Diabetes Phase 1
Not yet recruiting NCT06442150 - LCMD for Type 2 Diabetes Remission: Evaluation of Effectiveness and Exploration of Individual Differences N/A
Withdrawn NCT04910997 - Heart Rate Variability-Guided Exercise Training in Type 2 Diabetes N/A
Completed NCT04931836 - The Influence of Physical Activity on the Gut Microbiome of Pre-Diabetic Adults N/A
Recruiting NCT06005012 - Semaglutide Treatment in the Real-world for Fibrosis Due to NAFLD in Obesity and T2DM Phase 2
Completed NCT05409027 - A Study to Assess 11 Beta-hydroxysteroid Dehydrogenase Type 1 Inhibition in Adipose Tissue by SPI-62 Phase 1
Terminated NCT04741074 - Effect of Subcutaneous Semaglutide on Kidney Transplant Candidacy Phase 3
Recruiting NCT05838287 - Pioglitazone on Heart Failure in Type-2 Diabetes Mellitus Participants Phase 4
Active, not recruiting NCT04916314 - REmote SUpport for Low-Carbohydrate Treatment of Type 2 Diabetes N/A
Recruiting NCT05446415 - L-Cell Activity in Small Intestine as Biliopancreatic Loop in Obese Patients With DM2 Submitted to RYGBP N/A
Completed NCT05770076 - Probiotic Lysate (Postbiotic and Metabiotic) Supplementation for Type 2 Diabetes Patients (DELI_Diab Study) N/A
Completed NCT02937987 - Dietary Intake, Eating Behavior, Physical Activity Level and Their Relationships With Glycemic and Weight Control in Hong Kong Chinese Type 2 Diabetic Patients